Sotio Biotech
SOTIO is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.
Prague, Czech Republicwww.sotio.com ↗
Total raised
€280M
€280,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2021-12
latest 2021-12
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood12
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-02 | Other | €280M | PPF Group | View deal → |
Investors
1Related news
- Sotio Biotech Raises €280M in Fundingfinsmes.com · 2021-12
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech
- Doctolib€734MFrance · E-commerce